“Distribution of SALT Scores with Ritlecitinib Treatment up to 24 months from the ALLEGRO Phase 2b/3 and Long-Term Phase 3 Clinical Studies in Alopecia Areata” (2024) SKIN The Journal of Cutaneous Medicine, 8(6), p. s465. doi:10.25251/skin.8.supp.465.